Current Report Filing (8-k)
12 May 2022 - 06:14AM
Edgar (US Regulatory)
false000183233200018323322022-05-112022-05-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported):
May 11, 2022
Aveanna Healthcare Holdings Inc.
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
Delaware
|
001-40362
|
81-4717209
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
400 Interstate North Parkway SE,
Atlanta,
GA
30339
(Address of Principal Executive Offices, including Zip
Code)
|
(770)-441-1580
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.01 per share
|
|
AVAH
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02 Results of Operations and Financial Condition.
On May 11, 2022, Aveanna Healthcare Holdings Inc. (“we,” “us,”,
“our” or the “Company”) issued a press release announcing its
financial results for the three-month period ended April 2, 2022. A
copy of the press release is furnished as Exhibit 99.1 to this
Current Report on Form 8-K and incorporated by reference in this
Item 2.02.
Item 7.01 Regulation FD Disclosure.
The information contained in Item 2.02 of this Current Report on
Form 8-K is incorporated by reference in this Item 7.01.
The information contained in this Current Report on Form 8-K,
including in Exhibit 99.1 attached hereto, is “furnished” and not
“filed” for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities of that section. Such information shall not be
incorporated by reference in another filing under the Exchange Act
or the Securities Act of 1933, as amended, except to the extent
such other filing specifically incorporates such information by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
AVEANNA HEALTHCARE HOLDINGS INC.
|
|
|
|
|
|
|
Date: May 11, 2022
|
|
By:
|
/s/ David Afshar
|
|
|
|
|
David Afshar
|
|
|
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
Aveanna Healthcare (NASDAQ:AVAH)
Historical Stock Chart
From May 2022 to Jun 2022
Aveanna Healthcare (NASDAQ:AVAH)
Historical Stock Chart
From Jun 2021 to Jun 2022
